{"input_url":"https://www.quiverquant.com/news/Hims+%26+Hers+Health+Slides+as+Traders+Fade+Peptide+Rally","gnews_decode":"https://www.quiverquant.com/news/Hims+%26+Hers+Health+Slides+as+Traders+Fade+Peptide+Rally","http_status":200,"final_url":"https://www.quiverquant.com/news/Hims+%26+Hers+Health+Slides+as+Traders+Fade+Peptide+Rally","html_length":1928142,"trafilatura_result":"ok","text_length":4085,"text_preview":"Hims & Hers Health, Inc. (HIMS) is down 10.4% today. Here is some analysis on what might have caused this price movement.\nAnalysis: The most likely explanation is a sell-the-news reversal after a sharp rally tied to the FDA advisory committee’s favorable peptide votes. While that outcome supports Hi","verdict":"OK"}